A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation

NCT05049850 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision, not due to any safety reason

Conditions

Kidney Transplantation in Highly Sensitized Patients

Interventions

DRUG: Imlifidase

Sponsor

Hansa Biopharma AB